530317

Godavari Drugs Share PriceGodavari Drugs

₹91.5
-1.35 (-1.45%)
As on 01 October, 2023 | 11:20 BSE: 530317 NSE: GODAVARIISIN: INE362C01012

Godavari Drugs Performance

Day Range

  • Low
  • High
91.5

52 Week Range

  • Low
  • High
91.5
  • Open Price
  • Previous Close
  • Volume

Start SIP in Godavari Drugs

Start SIP

Godavari Drugs Share Price

  • Over 1 Month -10.69%
  • Over 3 Month -5.46%
  • Over 6 Month 17.41%
  • Over 1 Year 36.36%

Godavari Drugs Key Statistics

Godavari Drugs Investment Rating

  • Master Rating:
  • Godavari Drugs has an operating revenue of Rs. 152.49 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 3% needs improvement, ROE of 11% is good. The company has a reasonable debt to equity of 36%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Godavari Drugs Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 353739414344
Operating Expenses Qtr Cr 333537384042
Operating Profit Qtr Cr 232323
Depreciation Qtr Cr 001000
Interest Qtr Cr 111111
Tax Qtr Cr 000001
Net Profit Qtr Cr 111111
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 160161
Operating Expenses Annual Cr 150150
Operating Profit Annual in Cr 1011
Depreciation Cr 22
Interest Annual Cr 43
Tax Annual Cr 12
Net Profit Annual Cr 45
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 1311
Cash from Investing Activity Annual Cr -9-5
Cash from Financing Annual Activity Cr -4-6
Net Cash Flow Annual Cr 11
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 3330
Fixed Assets Annual Cr 3427
Total Non Current Assets Annual Cr 3427
Total Current Assets Annual Cr 8774
Total Assets Annual Cr 121101
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 4439
ROE Annual % 1118
ROCE Annual % 1823
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 77
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Godavari Drugs Technicals

EMA & SMA

Current Price
₹91.5
-1.35 (-1.45%)
  • Bullish Moving Average
  • ___
  • 3
  • Bearish Moving Average
  • ___
  • 13
  • 20 Day
  • ₹98.35
  • 50 Day
  • ₹98.89
  • 100 Day
  • ₹95.51
  • 200 Day
  • ₹89.19
  • 20 Day
  • ₹100.74
  • 50 Day
  • ₹100.84
  • 100 Day
  • ₹95.47
  • 200 Day
  • ₹88.93

Godavari Drugs Resistance and Support

PIVOT
₹92.32
Resistance
First Resistance ₹94.14
Second Resistance ₹96.77
Third Resistance ₹98.59
RSI 35.71
MFI 35.71
MACD Single Line -1.2
MACD -2.31
Support
First Resistance ₹89.69
Second Resistance ₹87.87
Third Resistance ₹85.24

Godavari Drugs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 22,869 1,780,580 77.86
Week 15,730 1,140,582 72.51
1 Month 25,100 1,750,497 69.74
6 Month 23,392 1,627,390 69.57

Godavari Drugs Result Highlights

Godavari Drugs Synopsis

BSE-Medical-Generic Drugs

Godavari Drugs is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 159.62 Cr. and Equity Capital is Rs. 7.53 Cr. for the Year ended 31/03/2023. Godavari Drugs Ltd. is a Public Limited Listed company incorporated on 02/12/1987 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230TG1987PLC008016 and registration number is 008016.
Market Cap 69
Sales 152
Shares in Float 0.35
No of funds 4
Yield
Book Value 2.06
U/D Vol ratio 1.4
LTDebt / Equity 36
Alpha 0.16
Beta 0.22

Godavari Drugs

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 53.16%53.12%53.12%56.92%
Financial Institutions/ Banks 0.5%0.5%0.5%0.5%
Individual Investors 38.75%7.27%39.26%35.9%
Others 7.59%39.11%7.12%6.68%

Godavari Drugs Management

Name Designation
Mr. Ghanshyam Jaju Chairman
Mr. Mukund Kakani Managing Director
Mr. Mohit Jaju WholeTime Director & CFO
Mr. Mahendra Bhalerao Non Exe. & Ind. Director
Mr. Dilip Keshavlal Patel Independent Director
Mr. Syed Anis Hussain Non Exe. & Ind. Director
Mr. Ramesh Babu Telugu Non Exe. & Ind. Director
Mrs. Vimala Madon Non Exe. & Ind. Director

Godavari Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Godavari Drugs Corporate Action

Date Purpose Remarks
2023-08-11 Quarterly Results
2023-05-29 Audited Results
2023-02-14 Quarterly Results
2022-11-12 Quarterly Results
2022-08-13 Quarterly Results
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Godavari Drugs FAQs

What is Share Price of Godavari Drugs ?

Godavari Drugs share price is ₹91 As on 01 October, 2023 | 11:06

What is the Market Cap of Godavari Drugs ?

The Market Cap of Godavari Drugs is ₹68.9 Cr As on 01 October, 2023 | 11:06

What is the P/E ratio of Godavari Drugs ?

The P/E ratio of Godavari Drugs is 18.8 As on 01 October, 2023 | 11:06

What is the PB ratio of Godavari Drugs ?

The PB ratio of Godavari Drugs is 2.1 As on 01 October, 2023 | 11:06

Q2FY23